Evaluating the bioequivalence and safety of liraglutide injection versus Victoza® in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial

• मुख्य लेखकों: Chao Liu (लेखक), Hongrong Xu (लेखक), Fei Yuan (लेखक), Hanjing Chen (लेखक), Lei Sheng (लेखक), Weili Chen (लेखक), Haisong Xie (लेखक), Hongmei Xu (लेखक), Xuening Li (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog, and its pharmacokinetic and pharmacodynamic properties as a GLP-1 receptor (GLP-1R) agonist make it an important therapeutic option for many patients with type 2 diabetes mellitus. This study compared the bioequivalence a...